We’re on it with the Canadian Biotechnology Innovation and Commercialization Program (CBIC)
Thanks to genomics, we now have a deeper understanding of the genetic basis of life, which has been driving innovation in health, food/agriculture and cleantech for years. Now, as part of Genome Canada’s strategic investment to promote genomics and biotech solutions, the focus is being put on commercialization so that more people can benefit from this progress. Ontario Genomics is leading a $3.3 million project that is aiming to make invasive prostate biopsies a last resort.
Every year in Canada, around 100,000 men undergo a prostate biopsy, an uncomfortable procedure that reveals high-grade (i.e. aggressive, requiring treatment) prostate cancer (HGPrCa) only 20 per cent of the time, and comes with a risk of complications. Researchers are now working on better predicting the risks of a patient having HGPrCa using biomarkers from semen instead. They’re also developing a home testing kit, which is easier for patients and a less invasive way for healthcare providers to identify if a biopsy is needed.
We’re on it with the Canadian Bioinformatics Hub (CBH)
As technology has evolved over the years, research projects have gotten bigger and more complex, leaving many of the people working on them with heaps of data and neither the time nor expertise to decipher it all. That’s where the CBH skills development and community engagement platform comes in.
This $6 million project housed at bioinformatics.ca is expanding Canada’s bioinformatics, computational biology and data science (BCBDS) training capacity while using an inclusion, diversity, equity and accessibility (IDEA) framework. The goal is to teach more researchers how to access, manage and study health and life science data so they’re better able to make important discoveries that lead to improvements in health care and beyond.
– Dr. Keith Jarvi (Sinai Health System)
– Dr. Brendan Mullen (FlowLabs Medical Laboratory)
– Dr. Michelle Brazas (Ontario Institute for Cancer Research)